HUTCHMED (China) Limited (HCM)
HUTCHMED (China) Statistics
Share Statistics
HUTCHMED (China) has 174.32M shares outstanding. The number of shares has increased by 0.03% in one year.
Shares Outstanding | 174.32M |
Shares Change (YoY) | 0.03% |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | 0.79% |
Shares Floating | 170.32M |
Failed to Deliver (FTD) Shares | 800 |
FTD / Avg. Volume | 0.81% |
Short Selling Information
The latest short interest is 373.29K, so 0.21% of the outstanding shares have been sold short.
Short Interest | 373.29K |
Short % of Shares Out | 0.21% |
Short % of Float | 0.22% |
Short Ratio (days to cover) | 3.9 |
Valuation Ratios
The PE ratio is 72.05 and the forward PE ratio is 23.56. HUTCHMED (China)'s PEG ratio is -1.09.
PE Ratio | 72.05 |
Forward PE | 23.56 |
PS Ratio | 4.31 |
Forward PS | 1.7 |
PB Ratio | 3.58 |
P/FCF Ratio | -155.91 |
PEG Ratio | -1.09 |
Enterprise Valuation
HUTCHMED (China) has an Enterprise Value (EV) of 13.53B.
EV / Sales | 21.47 |
EV / EBITDA | 959.03 |
EV / EBIT | 27219.46 |
EV / FCF | -775.87 |
Financial Position
The company has a current ratio of 2.83, with a Debt / Equity ratio of 0.12.
Current Ratio | 2.83 |
Quick Ratio | 2.7 |
Debt / Equity | 0.12 |
Debt / EBITDA | 6.37 |
Debt / FCF | -5.15 |
Interest Coverage | -14.14 |
Financial Efficiency
Return on Equity is 4.96% and Return on Invested Capital is -32.95%.
Return on Equity | 4.96% |
Return on Assets | 2.96% |
Return on Invested Capital | -32.95% |
Revenue Per Employee | $347.99K |
Profits Per Employee | $20.83K |
Employee Count | 1,811 |
Asset Turnover | 0.49 |
Inventory Turnover | 6.92 |
Taxes
Income Tax | 7.19M |
Effective Tax Rate | -649.68% |
Stock Price Statistics
The stock price has increased by -17.75% in the last 52 weeks. The beta is 0.72, so HUTCHMED (China)'s price volatility has been higher than the market average.
Beta | 0.72 |
52-Week Price Change | -17.75% |
50-Day Moving Average | 14.84 |
200-Day Moving Average | 16.78 |
Relative Strength Index (RSI) | 46.08 |
Average Volume (20 Days) | 99.19K |
Income Statement
In the last 12 months, HUTCHMED (China) had revenue of 630.2M and earned 37.73M in profits. Earnings per share was 0.04.
Revenue | 630.2M |
Gross Profit | 281.32M |
Operating Income | -40.61M |
Net Income | 37.73M |
EBITDA | 14.11M |
EBIT | 1.76M |
Earnings Per Share (EPS) | 0.04 |
Balance Sheet
The company has 153.96M in cash and 89.82M in debt, giving a net cash position of 64.14M.
Cash & Cash Equivalents | 153.96M |
Total Debt | 89.82M |
Net Cash | 64.14M |
Retained Earnings | -833.17M |
Total Assets | 1.27B |
Working Capital | 689.99M |
Cash Flow
In the last 12 months, operating cash flow was 497K and capital expenditures -17.93M, giving a free cash flow of -17.44M.
Operating Cash Flow | 497K |
Capital Expenditures | -17.93M |
Free Cash Flow | -17.44M |
FCF Per Share | -0.02 |
Margins
Gross margin is 44.64%, with operating and profit margins of -6.44% and 5.99%.
Gross Margin | 44.64% |
Operating Margin | -6.44% |
Pretax Margin | -0.18% |
Profit Margin | 5.99% |
EBITDA Margin | 2.24% |
EBIT Margin | -6.44% |
FCF Margin | -2.77% |
Dividends & Yields
HCM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 1.39% |
FCF Yield | -0.13% |
Analyst Forecast
The average price target for HCM is $19, which is 40.4% higher than the current price. The consensus rating is "Hold".
Price Target | $19 |
Price Target Difference | 40.4% |
Analyst Consensus | Hold |
Analyst Count | 1 |
Stock Splits
The last stock split was on May 30, 2019. It was a forward split with a ratio of 10:1.
Last Split Date | May 30, 2019 |
Split Type | forward |
Split Ratio | 10:1 |
Scores
Altman Z-Score | 3.22 |
Piotroski F-Score | 4 |